key: cord-1024698-xnvvx192
authors: Wang, Hai; Song, Jia; Pan, Li; Yao, Yin; Deng, Yi-Ke; Wang, Zhi-Chao; Liao, Bo; Ma, Jin; He, Chao; Zeng, Ming; Liu, Zheng
title: The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19
date: 2020-09-24
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2020.09.013
sha: 40e5bf28b624a2a37a40c7892388ccdeefc995ec
doc_id: 1024698
cord_uid: xnvvx192

nan

The prevalence of CRS in hospitalized COVID-19 patients in our cohort from 70 Wuhan, China, was 6.1%, which is close to CRS prevalence in the general population 71 in China (8%). CRS comorbidity was not associated with the risk of developing 72 severe illness of COVID-19. Here we retrospectively analyzed 1,172 COVID-19 patients who were 106 discharged from Tongji Hospital, Wuhan, China, from January 27, 2020 to March 10, 107 2020, and completed telephone follow-up within one month after discharge. The with and without CRS after PSM (Table E1) . Importantly, again, we did not find 151 significant differences in severe cases on admission, complications, in-hospital 152 treatments, and hospitalization days between patients with and without CRS by PSM 153 analysis (Table 2 and Table E1 ).

In this study, in order to reduce the bias caused by potentially incomplete 155 medical records on admission, we rechecked the records of comorbidities with patients by telephone follow-up. This may be the reason that the CRS prevalence 157 (6.1%) in our COVID-19 cohort was higher than those previously reported in China   158 and Europe (0%-3%), 2, 3 which is close to CRS prevalence in the general population 159 in China (8% Our report has several potential limitations. First, self-reported comorbidities 172 might lead to the potential misestimation of the prevalence. Second, in order to 173 confirm the comorbidities, we did telephone follow-up. We did not include fatal cases 174 in this report, because it was difficult to confirm those patients' comorbidities. 

Formation of nasal polyps: The roles of innate type 2 205 inflammation and deposition of fibrin

Implications of nasal diseases and consequences for their management

Olfactory 210 and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the 211 coronavirus disease (COVID-19): a multicenter European study

Diagnosis and 214 Treatment of Adults with Community-acquired Pneumonia

Epidemiology of chronic rhinosinusitis: 218 results from a cross-sectional survey in seven Chinese cities

Prevalence and 220 characterization of asthma in hospitalized and non-hospitalized patients with COVID-19

Longitudinal hematologic and immunologic 223 variations associated with the progression of COVID-19 patients in China

Haematological characteristics and risk 226 factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort 227 study